Literature DB >> 23207946

Oncological management of unresectable liver metastases.

Hans Prenen1, Eric Van Cutsem.   

Abstract

Surgical resection of liver metastases of colorectal cancer can improve clinical outcome and even cure some patients with metastatic disease. For patients with unresectable liver metastases, the ultimate treatment goal is to let them become eligible for resection. In recent years, considerable attention has been paid to molecular targeted therapies to improve the efficacy of the available chemotherapeutic regimens in order to increase the downsizing rate of liver metastases and increase resectability. This overview will focus on the oncological management and chemotherapeutic options of patients with unresectable liver metastases.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23207946     DOI: 10.1159/000342047

Source DB:  PubMed          Journal:  Dig Dis        ISSN: 0257-2753            Impact factor:   2.404


  6 in total

1.  Current treatment options for patients with initially unresectable isolated colorectal liver metastases.

Authors:  Ozkan Kanat
Journal:  World J Clin Oncol       Date:  2016-02-10

2.  Third-line treatment of colorectal liver metastases using DEBIRI chemoembolization.

Authors:  Germano Scevola; Giorgio Loreni; Marco Rastelli; Stefano Sposato; Sara Ramponi; Vittorio Miele
Journal:  Med Oncol       Date:  2017-02-03       Impact factor: 3.064

3.  Small-size (40 µm) Beads Loaded with Irinotecan in the Treatment of Patients with Colorectal Liver Metastases.

Authors:  Giovanni Mauri; Duccio Rossi; Samuele Frassoni; Guido Bonomo; Nicola Camisassi; Paolo Della Vigna; Vincenzo Bagnardi; Daniele Maiettini; Gianluca Maria Varano; Maria Giulia Zampino; Franco Orsi
Journal:  Cardiovasc Intervent Radiol       Date:  2022-01-14       Impact factor: 2.740

4.  Characterization of Liver Metastases During Catheter-Directed Liver Interventions: A Comparison between Dual Phase Cone-Beam Computed Tomography and Conventional Contrast-Enhanced Computed Tomography.

Authors:  Geert Maleux; Maria-Louisa Izamis; Cedric Werbrouck; Alessandro Radaelli; Hans Prenen; Eric Van Cutsem; Vincent Vandecaveye
Journal:  J Belg Soc Radiol       Date:  2020-07-08       Impact factor: 1.894

Review 5.  Intrahepatic therapy for liver-dominant metastatic colorectal cancer.

Authors:  Kerlijne De Groote; Hans Prenen
Journal:  World J Gastrointest Oncol       Date:  2015-09-15

6.  Long-term survival after percutaneous irreversible electroporation of inoperable colorectal liver metastases.

Authors:  Andreas Schicho; Christoph Niessen; Michael Haimerl; Isabel Wiesinger; Christian Stroszczynski; Lukas P Beyer; Philipp Wiggermann
Journal:  Cancer Manag Res       Date:  2018-12-27       Impact factor: 3.989

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.